Study number 781667
Dates
Apr 23 2026-Aug 21 2026
Location
Madison, Wisconsin
Age
18-55
Gender
Male OR Female
Smoker
Yes
Compensation
$12,041 to $13,189
Group
Part 2 Cohort 2
The investigational drug in this research study is being developed as a possible treatment for chronic immune-related inflammatory conditions, long-lasting, overactive immune system responses that cause inflammation though the body. To make it easier for patients to self-inject treatment, a new type of automatic injection device (autoinjector) has been developed.
Madison, WI is currently recruiting Healthy Adults, ages 18-55.
Refer a friend & receive $500 per qualified referral
Women Eligibility Criteria
Body Mass Index
Smoking criteria
Screening procedures
Call Now to Schedule Your Screening Appointment!
Check-in: Apr 23
Check-out: Apr 25
Follow up Visits:
Apr 28
May 1, 8, 15, 22
Jun 5, 19
Jul 17
Aug 7 &21
*Designs are selected after enrollment based on research needs.